Newsletter

128940 - Hanmi Pharm. Co., Ltd.

128940 Summary
Biopharma
Stock Price & Overview
₩473,500 +13,000 (+2.82%) Close · Sep 4, 2026 KST
KOSPI | ₩KRW | Close: ₩473,500  ≈ US$338  ·  Market cap ₩6.1tn (≈ $4.3bn)
What kstock news is. Short items on what actually happened — a filing, an order, a buyback, a result — written from the Korean filing or the Korean press for people who cannot read either. Each one puts the event against a figure from this company's own statements. No view, no rating; that is what analysis is for.

128940 News

All kstock news »
ks

Hanmi Pharm distributes more treasury shares to staff than planned

Hanmi Pharmaceutical (128940) disposed of 11,180 common treasury shares to employees and officers on August 4 at KRW 345,500, the prior day's close, for a total of KRW 3.86 billion, the company said in a filing.

kstock NewsSep 2, 6:44 PM
1 item. Written from DART filings and Korean press reports; every item lists its source.

Similar to 128940

SymbolLast Price
326030SK biopharmaceuticals Co., Ltd.₩86,600
+0.2%
000100Yuhan Corporation₩81,400
+0.0%
028300HLB Co., Ltd.₩33,750
+2.9%
298380ABL Bio Inc.₩71,400
+5.6%
000250Samchundang Pharm₩157,000
+1.0%
087010Peptron, Inc.₩157,300
+7.3%
141080LigaChem Biosciences Inc.₩92,000
+4.2%
145020Hugel, Inc.₩244,000
+1.5%
302440SK Bioscience Co., Ltd.₩37,900
+0.4%
009420Hanall Biopharma Co., Ltd.₩54,700
+1.5%
Compare all 48 in Biopharma

What a US investor should know

  • Trading hours09:00–15:30 KST — 20:00–02:30 US Eastern the night before.
  • Daily limitKorean stocks can move at most ±30% in a session before trading halts.
  • Getting exposureKRX shares are not directly tradable in most US brokerage accounts. The usual routes are Korea ETFs or an international account.
  • ReportingKorean issuers file to DART, not the SEC. Half-year and quarterly reports land about 45 days after period end.